Mesoporous Hydroxyapatite as Drug Carrier for Long-acting Antidepression Treatment and Stimulation of Exosome
博士 === 國立臺灣大學 === 醫學工程學研究所 === 105 === An antidepressant carrier was designed to maintain over two weeks of constant medication release. The carrier was injected into muscle where cellular activity was involved to achieve the goal of constant release. Meso-porous hydroxyapatite (mesoHAP) was synthes...
Main Authors: | Yan-Jye Shyong, 熊彥傑 |
---|---|
Other Authors: | Feng-Huei Lin |
Format: | Others |
Language: | en_US |
Published: |
2017
|
Online Access: | http://ndltd.ncl.edu.tw/handle/h8ns54 |
Similar Items
-
Mesoporous Hydroxyapatite Nanoparticle as Antidepressant Drug Carrier
by: Cheng Chen, et al.
Published: (2010) -
Mesoporous Hydroxyapatite Particles as Olanzapine Carrier for Long-acting Delivery in Anti-depression Treatment
by: Lee, Cheng-Che, et al.
Published: (2013) -
Hydroxyapatite and Silicon-Modified Hydroxyapatite as Drug Carriers for 4-Aminopyridine
by: Laura Marincaș, et al.
Published: (2021-09-01) -
Synthesis of Hollow Mesoporous Hydroxyapatite Nanoparticles for Intracellular Drug Delivery
by: Ya-Heui Yang, et al.
Published: (2011) -
Exosomes as drug carriers for cancer therapy and challenges regarding exosome uptake
by: Xiaoyin Zhao, et al.
Published: (2020-08-01)